Literature DB >> 9073025

Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings.

E Hund1, A Grau, W Fogel, M Forsting, M Cantz, B Kustermann-Kuhn, K Harzer, R Navon, H H Goebel, H M Meinck.   

Abstract

Tay-Sachs disease is a genetically determined neurodegenerative disorder, resulting from mutations of the hexosaminidase (Hex) A gene coding for the alpha-subunit of beta-D-N-acetyl-hexosaminidase. Clinically, there is severe encephalomyelopathy leading to death within the first few years of life. Hex A activity is usually absent in tissue and body fluids of these patients. Juvenile and adult Hex A deficiencies are less severe but rare variants with some residual Hex A activity. All these variants are most prevalent among Ashkenazi Jews. We describe a non-Jewish family in which four adult brothers and sisters had markedly reduced Hex A activities and onset of symptoms in the second decade of life. The phenotypical expression was remarkably homogeneous, consisting in a combination of slowly progressive motor neuron disease, ataxia and ocular motor disturbances. None of the patients were demented at this stage of their illness. Magnetic resonance studies showed severe cerebellar atrophy, but were otherwise normal. Hex A deficiency was established by biochemical measurements in the serum and skin fibroblasts using the fluorogenic substrates 4-MUG and 4-MUGS as well as by gel electrophoresis. Molecular genetic studies revealed that the patients are compound heterozygotes for the 'adult' mutation Gly269 --> Ser and the 'infantile' 4-base insertion in exon 11 of the Hex A gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073025     DOI: 10.1016/s0022-510x(96)00233-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Unusual presentation of GM2 gangliosidosis mimicking a brain stem tumor in a 3-year-old girl.

Authors:  Marie-Cécile Nassogne; Marie-Christine Commare; Arielle Lellouch-Tubiana; Sophie Emond; Michel Zerah; Catherine Caillaud; Lucie Hertz-Pannier; Jean-Marie Saudubray
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Neurocognitive testing in late-onset Tay-Sachs disease: a pilot study.

Authors:  D Elstein; G M Doniger; E Simon; I Korn-Lubetzki; R Navon; A Zimran
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.982

Review 3.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

Review 4.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.

Authors:  Jitka Májovská; Anita Hennig; Igor Nestrasil; Susanne A Schneider; Helena Jahnová; Manuela Vaněčková; Martin Magner; Petr Dušek
Journal:  Neurol Sci       Date:  2021-11-20       Impact factor: 3.830

6.  Newly observed thalamic involvement and mutations of the HEXA gene in a Korean patient with juvenile GM2 gangliosidosis.

Authors:  Soon Min Lee; Min Jung Lee; Joon Soo Lee; Heung Dong Kim; Jin Sung Lee; Jinna Kim; Seung Koo Lee; Young Mock Lee
Journal:  Metab Brain Dis       Date:  2008-07-23       Impact factor: 3.584

7.  Dysarthria and Stutter as Presenting Symptoms of Late-Onset Tay-Sachs Disease in Three Siblings.

Authors:  Kristina K Grim; Gregory D Phillips; David R Renner
Journal:  Mov Disord Clin Pract       Date:  2015-06-30

8.  Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.

Authors:  Olivia E Rowe; D Rangaprakash; Akila Weerasekera; Neha Godbole; Elizabeth Haxton; Peter F James; Christopher D Stephen; Robert L Barry; Florian S Eichler; Eva-Maria Ratai
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.204

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.